BBLG Short Volume
Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $2.4M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Led by Jeffrey Frelick, public since 2021-10-13.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 2.1K
- Total Volume
- 5.5K
- Short %
- 39.06%
- 30-Day Avg Short %
- 33.03%
Showing 30 days of FINRA short volume data for Bone Biologics Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked BBLG short volume questions
- What is the daily BBLG short volume?
- As of Jun 1, 2026, Bone Biologics Corporation (BBLG) short volume is 2.1K shares against 5.5K total reported volume, or 39.06% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is BBLG short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does BBLG short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.